School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Kathryn Leung

  • Department of Pediatrics
    Associate Professor
  • kathryn.leung@emory.edu
  • Children's Healthcare of Atlanta Provider Profile
  • Aflac Cancer & Blood Disorders Center
    Pediatrics
    2015 Uppergate Drive
Head shot of Kathryn Leung

Academic Appointment

  • Associate Professor of Pediatrics, Emory University

Education

Degrees

  • MD from Oregon Health & Science University, Portland
  • BS from Santa Clara University, Santa Clara

Research

Publications

  • Engraft: A Collaborative Learning Health Network for Enhanced Transplant and Cellular Therapy Outcomes.
    Transplant Cell Ther Volume: 31 Page(s): 123 - 134
    03/01/2025 Authors: Dandoy CE; Auletta JJ; Badia P; Bidgoli A; Daraiseh NM; DeSalvo AM; Diaz J; Davies SM; Demmel K; Cook E
  • Hematopoietic stem cell transplantation for B-thalassemia major with alemtuzumab.
    Pediatr Hematol Oncol Volume: 41 Page(s): 260 - 272
    05/01/2024 Authors: Snchez LM; George A; Friend BD; Bhar S; Sasa G; Doherty EE; Craddock J; Steffin D; Salem B; Yassine K
  • Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial.
    Am J Hematol Volume: 99 Page(s): 785 - 788
    04/01/2024 Authors: Eapen M; Kou J; Andreansky M; Bhatia M; Brochstein J; Chaudhury S; Haight AE; Haines H; Jacobsohn D; Jaroscak J
  • Short-Course Empiric Antibiotics in Children Undergoing Allogeneic Hematopoietic Cell Transplantation.
    Transplant Cell Ther Volume: 29 Page(s): 778.e1 - 778.e6
    12/01/2023 Authors: Patel PA; Teherani MF; Xiang Y; Bernardo V; Chandrakasan S; Goggin KP; Haight A; Horwitz E; Liang WH; Parikh SH
  • Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure.
    Blood Adv Volume: 7 Page(s): 2196 - 2205
    05/23/2023 Authors: Stenger EO; Watkins B; Rogowski K; Chiang K-Y; Haight A; Leung K; Qayed M; Raghunandan S; Suessmuth Y; Kean L
  • BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma.
    J Immunother Cancer Volume: 11
    05/01/2023 Authors: Raghunandan S; Pauly M; Blum WG; Qayed M; Dhodapkar MV; Elkhalifa M; Watkins B; Schoettler M; Horwitz E; Parikh S
  • BCMA CAR-T AFTER ALLOGENEIC HCT INDUCES REMISSION IN REFRACTORY PLASMABLASTIC LYMPHOMA
    Volume: 69
    06/01/2022 Authors: Raghunandan S; Pauly M; Blum W; Qayed M; Dhodapkar M; Elkhalifa M; Watkins B; Schoettler M; Horwitz E; Parikh S
  • REDUCING DURATION OF EMPIRIC ANTIBIOTICS IN CHILDREN UNDERGOING STEM CELL TRANSPLANTATION
    Volume: 69
    06/01/2022 Authors: Patel P; Teherani M; Xiang Y; Bernardo V; Chandrakasan S; Goggin K; Haight A; Horwitz E; Liang W; Parikh S
  • Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation.
    Blood Adv Volume: 6 Page(s): 3058 - 3061
    05/24/2022 Authors: Janardan S; Horwitz E; Watkins B; Williams K; Chandrakasan S; Qayed M; Parikh S; Arnold S; Keller F; Alazraki A
  • Matched related hematopoietic cell transplant for sickle cell disease with alemtuzumab: the Texas Children's Hospital experience.
    Bone Marrow Transplant Volume: 56 Page(s): 2797 - 2803
    11/01/2021 Authors: John TD; Friend B; Yassine K; Sasa G; Bhar S; Salem B; Omer B; Craddock J; Doherty E; Martinez C
  • Application of Alemtuzumab to Myeloablative Conditioning in Transfusion Dependent Beta-Thalassemia to Reduce Graft-Versus-Host Disease (GVHD)
    Volume: 26 Page(s): S222 - S222
    03/01/2020 Authors: George A; Yassine K; Doherty EE; Steffin DHM; Craddock J; Naik S; Sasa G; Omer B; Bhar S; Martinez C
  • "Mini" bank of only 8 donors supplies CMV-directed T cells to diverse recipients.
    Blood Adv Volume: 3 Page(s): 2571 - 2580
    09/10/2019 Authors: Tzannou I; Watanabe A; Naik S; Daum R; Kuvalekar M; Leung KS; Martinez C; Sasa G; Wu M; Gee AP
  • Myeloablative Conditioning with Alemtuzumab in Matched Related Donor Hematopoietic Cell Transplant for Sickle Cell Disease Prevents Graft-Versus-Host Disease without Compromising Engraftment
    Volume: 25
    03/01/2019 Authors: John T; Yassine K; Naik S; Sasa G; Omer B; Martinez C; Tewari P; Krance RA; Leung KS
  • High Incidence of Autoimmune Disease after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease.
    Biol Blood Marrow Transplant Volume: 24 Page(s): 1643 - 1650
    08/01/2018 Authors: Yanir AD; Hanson IC; Shearer WT; Noroski LM; Forbes LR; Seeborg FO; Nicholas S; Chinn I; Orange JS; Rider NL
  • Allogeneic hematopoietic cell transplant following crizotinib monotherapy for relapsed/refractory anaplastic large cell lymphoma.
    Pediatr Transplant Volume: 22 Page(s): e13210
    08/01/2018 Authors: John TD; Naik S; Leung K; Sasa G; Martinez C; Krance RA
  • Current Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphocytic Leukemia: Success, Failure and Future Perspectives-A Single-Center Experience, 2008 to 2016.
    Biol Blood Marrow Transplant Volume: 24 Page(s): 1424 - 1431
    07/01/2018 Authors: Yanir AD; Martinez CA; Sasa G; Leung K; Gottschalk S; Omer B; Ahmed N; Hegde M; Eunji J; Liu H
  • Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome.
    Biol Blood Marrow Transplant Volume: 24 Page(s): 537 - 541
    03/01/2018 Authors: Ngwube A; Hanson IC; Orange J; Rider NL; Seeborg F; Shearer W; Noroski L; Nicholas S; Forbes L; Leung K
  • Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation.
    J Clin Oncol Volume: 35 Page(s): 3547 - 3557
    11/01/2017 Authors: Tzannou I; Papadopoulou A; Naik S; Leung K; Martinez CA; Ramos CA; Carrum G; Sasa G; Lulla P; Watanabe A
  • Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation.
    Blood Volume: 129 Page(s): 1548 - 1556
    03/16/2017 Authors: Gluckman E; Cappelli B; Bernaudin F; Labopin M; Volt F; Carreras J; Pinto Simes B; Ferster A; Dupont S; de la Fuente J
  • Administration of Banked, 3rd Party Multivirus-Specific T Cells to Treat Drug-Refractory EBV, CMV, AdV, HHV6, and BKV Infections in Allogeneic Hematopoietic Stem Cell Transplant Recipients
    Volume: 23 Page(s): S53 - S54
    03/01/2017 Authors: Tzannou I; Papadopoulou A; Watanabe A; Kuvalekar M; Gee AP; Naik S; Martinez C; Leung K; Sasa G; Krance RA
  • Umbilical Cord Transplant (UCBT) Without Serotherapy for Malignant and Non Malignant Diseases Provides a Curative Alternative with Improved Immune Reconstitution
    Volume: 23 Page(s): S119 - S119
    03/01/2017 Authors: Aguayo-Hiraldo PI; Forbes L; Shearer W; Orange J; Naik S; Sasa G; Leung K; Gottschalk S; Allen C; Ahmed N
  • Umbilical Cord Blood Transplantation Conditioned without Serotherapy is an Excellent Curative Alternative for Pediatric Non-Malignant Diseases
    Volume: 23 Page(s): S241 - S241
    03/01/2017 Authors: Martinez C; Rider NI; Orange J; Shearer W; Forbes L; Leung K; Naik S; Gottschalk S; Allen C; Ahmed N
  • Haploidentical Hematopoietic Stem Cell Transplantation with CD34 Positive Selection in Children with Hematological Malignancy- a Single Center Experience of 16 Years
    Volume: 23 Page(s): S124 - S124
    03/01/2017 Authors: Yanir A; Naik S; Gottschalk S; Martinez C; Leung K; Sasa G; Hegde M; Ahmed N; Omer B; Allen C
  • The Use of Donor Lymphocyte Infusions As Prophylaxis and Treatment for Relapse in Children Post Hematopoietic Cell Transplant for Malignant Disease: A Single Institution Experience
    Volume: 23 Page(s): S322 - S323
    03/01/2017 Authors: John T; Leung K; Gottschalk S; Sasa G; Ahmed N; Allen C; Naik S; Hegde M; Omer B; Brenner MK
  • Chronic GvHD Incidence and Outcome: Single Center Experience
    Volume: 23 Page(s): S246 - S246
    03/01/2017 Authors: Shubert S; Elsabbagh EM; Leung K; Naik S; Gottschalk S; Allen C; Ahmed N; Sasa G; Hegde M; Omer B
  • A trial of unrelated donor marrow transplantation for children with severe sickle cell disease.
    Blood Volume: 128 Page(s): 2561 - 2567
    11/24/2016 Authors: Shenoy S; Eapen M; Panepinto JA; Logan BR; Wu J; Abraham A; Brochstein J; Chaudhury S; Godder K; Haight AE
  • Umbilical Cord Blood Transplantation Conditioned Without Serotherapy Is an Excellent Curative Alternative for Pediatric Non-Malignant Diseases
    Volume: 56 Page(s): 12A - 12A
    06/01/2016 Authors: Martinez C; Rider N; Forbes L; Shearer W; Orange J; Rosenblatt H; Leung K; Naik S; Gottschalk S; Omer B
  • Respiratory Viral Infections after Hematopoietic Stem Cell Transplants : The Texas Children's Hospital Experience
    Volume: 22 Page(s): S256 - S257
    03/01/2016 Authors: Whittle S; Nguyen N-Y; Aguayo-Hiraldo P; Leung K; Martinez C; Sasa G; Omer B; Gottschalk S; Heslop HE; Brenner MK
  • A PHASE 1 Perspective: Multivirus-Specific T CELLS from BOTH Cord Blood and BONE Marrow Transplant Donors
    Volume: 22 Page(s): S140 - S141
    03/01/2016 Authors: Hanley PJ; Keller MD; Manso MM; Martinez C; Leung K; Cruz CRY; Barese C; McCormack S; Luo M; Krance RA
  • Purtscher-like Retinopathy: A Rare Complication of HSCT-Associated Thrombotic Microangiopathy
    Volume: 22 Page(s): S428 - S429
    03/01/2016 Authors: Voigt KL; Castillo P; Crockett C; Martinez C; Leung K; Sasa G; Garoon R; Krance RA; Naik S
  • Invasive Fungal Infections after Hematopoietic Stem Cell Tranplant Recipients : Texas Children's Hospital Experience
    Volume: 22 Page(s): S242 - S242
    03/01/2016 Authors: Dutta A; Ngoc-Yen N; Castillo P; Wu V; Leung K; Martinez C; Sasa G; Heslop HE; Brenner MK; Krance RA
  • Long-Term Organ Function in Children Following Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease
    Volume: 22 Page(s): S239 - S240
    03/01/2016 Authors: Cain AN; Hanson IC; Forbes L; Seeborg FO; Noroski LM; Orange J; Rider NI; Shearer W; Leung K; Naik S
  • Administration of Most Closely HLA-Matched Multivirus-Specific T Cells for the Treatment of EBV, CMV, AdV, HHV-6, and BKV Post Allogeneic Hematopoietic Stem Cell Transplant
    Volume: 22 Page(s): S45 - S45
    03/01/2016 Authors: Tzannou I; Papadopoulou A; Koottiyaniyil N; Gee AP; Naik S; Martinez C; Leung K; Sasa G; Krance RA; Carrum G
  • Outcomes after Matched Unrelated Donor Stem Cell Transplantation in Chronic Granulomatous Disease - an Update
    Volume: 22 Page(s): S378 - S378
    03/01/2016 Authors: Yanir A; Hanson IC; Forbes L; Seeborg FO; Noroski LM; Orange J; Rider NI; Shearer W; Leung K; Naik S
  • Matched Unrelated Allogeneic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia: Texas Children's Hospital Experience
    Volume: 22 Page(s): S237 - S237
    03/01/2016 Authors: Bhar S; Yassine K; Martinez C; Sasa G; Naik S; Mahoney D; Bertuch A; Allen C; Ahmed NM; Hegde M
  • Intravesicular Cidofovir for BK Hemorrhagic Cystitis in Pediatric Patients after Hematopoietic Stem Cell Transplant
    Volume: 22 Page(s): S163 - S164
    03/01/2016 Authors: Foster J; Cheng WS; Leung K; Naik S; Gottschalk S; Allen C; Ahmed N; Sasa G; Hegde M; Omer B
  • IVIG Prophylaxis in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant: A Retrospective Analysis of Monthly Intravenous Immunoglobulin Infusion vs. IgG Level Based Dosing
    Volume: 22 Page(s): S244 - S244
    03/01/2016 Authors: Foster J; Cheng WS; Shubert S; Leung K; Naik S; Gottschalk S; Allen C; Ahmed N; Sasa G; Hegde M
  • Allogeneic Stem Cell Transplantation in a Pediatric Patient with Whim Syndrome
    Volume: 22 Page(s): S238 - S238
    03/01/2016 Authors: Bhar S; Yassine K; Martinez C; Sasa G; Naik S; Mahoney D; Allen C; Ahmed N; Hegde M; Heslop HE
  • Matched Unrelated Allogeneic Stem Cell Transplantation for Patients with Congenital Amegakaryocytic Thrombocytopenia: Texas Children's Hospital Experience
    Volume: 126
    12/03/2015 Authors: Bhar S; Yassine K; Martinez C; Sasa GS; Naik S; Mahoney D; Bertuch AA; Allen C; Ahmed N; Hegde MG
  • Allogeneic Stem Cell Transplantation in a Pediatric Patient with Whim Syndrome
    Volume: 126
    12/03/2015 Authors: Bhar S; Yassine K; Martinez C; Sasa GS; Naik S; Mahoney D; Allen C; Ahmed N; Hegde MG; Heslop HE
  • Autoimmune Encephalitis Following Bone Marrow Transplantation.
    Pediatr Neurol Volume: 53 Page(s): 253 - 256
    09/01/2015 Authors: Rathore GS; Leung KS; Muscal E
  • Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies.
    Biol Blood Marrow Transplant Volume: 21 Page(s): 1266 - 1272
    07/01/2015 Authors: Naik S; Martinez C; Leung K; Sasa G; Nguyen N-Y; Wu M-F; Gottschalk S; Brenner M; Heslop H; Krance R
  • Excellent Outcomes after Umbilical Cord Blood Transplantation for Pediatric Disorders Conditioned Without Serotherapy
    Volume: 55 Page(s): 3A - 3A
    06/01/2015 Authors: Aguayo-Hiraldo P; Leung K; Naik S; Gottschalk S; Allen C; Nabil A; Sasa G; Brenner M; Heslop H; Leen A
  • CMV-specific T cells generated from nave T cells recognize atypical epitopes and may be protective in vivo.
    Sci Transl Med Volume: 7 Page(s): 285ra63
    04/29/2015 Authors: Hanley PJ; Melenhorst JJ; Nikiforow S; Scheinberg P; Blaney JW; Demmler-Harrison G; Cruz CR; Lam S; Krance RA; Leung KS
  • STEM CELL TRANSPLANTATION AND LONG-TERM SURVIVAL FOR PRIMARY IMMUNODEFICIENCIES: OUTCOMES AMONG THE DONOR SOURCES AND DIFFERENT DIAGNOSTIC GROUPS
    Volume: 35 Page(s): 320 - 321
    04/01/2015 Authors: Martinez C; Forbes LR; Shearer W; Nicholas SK; Orange J; Rosenblatt H; Naik S; Sasa G; Leung K; Brenner M
  • Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Lymphoma Post Allogeneic Stem Cell Transplant
    Volume: 21 Page(s): S148 - S148
    02/01/2015 Authors: Perna SK; Gottschalk S; Torrano V; Diouf O; Miller RP; Carrum G; Ramos CA; Liu H; Wu M-F; Krance RA
  • Umbilical Cord Blood Transplantation Conditioned without Serotherapy Is an Excellent Curative Alternative for Pediatric Non-Malignant Diseases
    Volume: 21 Page(s): S103 - S104
    02/01/2015 Authors: Martinez C; Forbes L; Shearer W; Rosenblatt H; Leung K; Naik S; Gottschalk S; Allen C; Ahmed NM; Sasa G
  • Mixed Donor Chimerism after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome
    Volume: 21 Page(s): S236 - S236
    02/01/2015 Authors: Ngwube A; Forbes L; Krance RA; Brenner M; Heslop HE; Leung K; Hanson IC; Sasa G; Rosenblatt H; Leen AM
  • Outcomes after Allogeneic Stem Cell Transplantation for Patients with Non-Hodgkin Lymphoma: Texas Children's Hospital Experience 1999-2013
    Volume: 21 Page(s): S211 - S212
    02/01/2015 Authors: Naik S; Castillo P; Martinez C; Leung K; Sasa G; Gottschalk S; Ahmed NM; Allen C; Krance RA; Brenner MK
  • CMVpp65-Specific T Cells Generated from Naive T Cell Populations Recognize Atypical but Not Canonical Epitopes and May Be Protective In Vivo
    Volume: 21 Page(s): S51 - S52
    02/01/2015 Authors: Hanley PJ; Melenhorst J; Nikiforow S; Scheinberg P; Cruz R; Krance RA; Leung K; Martinez C; Heslop HE; Rooney CM
  • Opportunities and challenges of proteomics in pediatric patients: circulating biomarkers after hematopoietic stem cell transplantation as a successful example.
    Proteomics Clin Appl Volume: 8 Page(s): 837 - 850
    12/01/2014 Authors: Paczesny S; Duncan C; Jacobsohn D; Krance R; Leung K; Carpenter P; Bollard C; Renbarger J; Cooke K
  • Donor Cell-Derived Myelodysplastic Syndrome in Pediatric Hematopoietic Transplant Recipients: Clinicopathologic Analysis of Two Cases
    Volume: 142
    10/01/2014 Authors: Wiszniewska J; Leung K; Sasa G; Elghetany MT; Punia J
  • Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.
    Sci Transl Med Volume: 6 Page(s): 242ra83
    06/25/2014 Authors: Papadopoulou A; Gerdemann U; Katari UL; Tzannou I; Liu H; Martinez C; Leung K; Carrum G; Gee AP; Vera JF
  • Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene.
    Blood Volume: 123 Page(s): 3895 - 3905
    06/19/2014 Authors: Zhou X; Di Stasi A; Tey S-K; Krance RA; Martinez C; Leung KS; Durett AG; Wu M-F; Liu H; Leen AM
  • ACTIVITY OF RAPIDLY-GENERATED BROAD-SPECTRUM T CELLS AS TREATMENT FOR ADENOVIRUS, EBV, CMV, BK VIRUS AND HHV6 INFECTIONS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Volume: 99 Page(s): 269 - 269
    06/01/2014 Authors: Papadopoulou A; Gerdemann U; Katari U; Tzannou I; Liu H; Martinez C; Leung K; Carrum G; Gee A; Juan V
  • Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity.
    Clin Cancer Res Volume: 20 Page(s): 2215 - 2225
    04/15/2014 Authors: Kennedy-Nasser AA; Ku S; Castillo-Caro P; Hazrat Y; Wu M-F; Liu H; Melenhorst J; Barrett AJ; Ito S; Foster A
  • SAFETY AND CLINICAL EFFICACY OF RAPIDLY-GENERATED VIRUS-SPECIFIC T CELLS WITH ACTIVITY AGAINST ADV, EBV, CMV, HHV6 AND BK VIRUS ADMINISTERED AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT
    Volume: 16 Page(s): S7 - S7
    04/01/2014 Authors: Papadopoulou A; Katari UL; Gerdemann U; Tzannou I; Martinez C; Leung K; Carrum G; Gee A; Vera J; Krance RA
  • ULTRA LOW-DOSE IL-2 MEDIATED EXPANSION OF REGULATORY T CELLS AS GVHD PROPHYLAXIS FOR RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELLS
    Volume: 49 Page(s): S242 - S242
    03/01/2014 Authors: Bollard C; Kennedy-Nasser A; Barrett AJ; Ito S; Yvon E; Krance R; Leung K; Heslop HE; Brenner K
  • Outcome after Allogeneic Stem Cell Transplant for Patients with Hematological Malignancies and Associated Chromosome 7 Deletions
    Volume: 20 Page(s): S178 - S178
    02/01/2014 Authors: Naik S; Okur F; Omer B; Rao P; Martinez C; Leung K; Wu J; Ahmed N; Allen C; Gottschalk S
  • Safety and Clinical Efficacy of Rapidly-Generated Virus-Specific T Cells with Activity Against Adv, EBV, CMV, HHV6 and BK Virus Administered after Allogeneic Hematopoietic Stem Cell Transplant
    Volume: 20 Page(s): S48 - S48
    02/01/2014 Authors: Papadopoulou A; Katari UL; Gerdemann U; Tzannou I; Martinez C; Leung K; Carrum G; Gee AP; Vera JF; Krance RA
  • Umbilical Cord Blood Transplantation Can be an Effective Therapy for Patients with Primary Immunodeficiency Diseases Who Lack an HLA-Matched Related Donor
    Volume: 20 Page(s): S175 - S176
    02/01/2014 Authors: Martinez C; Shearer W; Orange J; Rosenblatt H; Leung K; Naik S; Gottschalk S; Allen C; Ahmed N; Sasa G
  • Outcome after Stem Cell Transplant in Patients with Dyskeratosis Congenita
    Volume: 20 Page(s): S178 - S179
    02/01/2014 Authors: Naik S; Sasa G; Bertuch A; Martinez C; Omer B; Allen C; Ahmed N; Gottschalk S; Heslop HE; Brenner MK
  • Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant.
    Mol Ther Volume: 21 Page(s): 2113 - 2121
    11/01/2013 Authors: Gerdemann U; Katari UL; Papadopoulou A; Keirnan JM; Craddock JA; Liu H; Martinez CA; Kennedy-Nasser A; Leung KS; Gottschalk SM
  • Safety and Efficacy of Rapidly-Generated Trivirus-Directed T Cells After Allogeneic Hematopoietic Stem Cell Transplant
    Volume: 19 Page(s): S111 - S111
    02/01/2013 Authors: Gerdemann U; Katari U; Keirnan J; Papadopoulou A; Craddock J; Liu H; Martinez C; Kennedy-Nasser A; Leung K; Gottschalk S
  • Outcomes in Pediatric Patients With Engraftment Failure After Allogeneic Transplants
    Volume: 19 Page(s): S253 - S254
    02/01/2013 Authors: Naik S; Martinez C; Bollard CM; El-Bietar JA; Gottschalk S; Leung K; Ahmed NM; Allen C; Heslop HE; Brenner MK
  • Outcomes After Second Allogeneic Transplants in Pediatric Patients With Relapsed Hematological Malignancies
    Volume: 19 Page(s): S253 - S253
    02/01/2013 Authors: Naik S; Martinez C; Bollard CM; El-Bietar JA; Gottschalk S; Leung K; Allen C; Ahmed NM; Heslop HE; Brenner MK
  • B Cell Engraftment in SCID Patients After Stem Cell Transplantation
    Volume: 19 Page(s): S205 - S206
    02/01/2013 Authors: Martinez C; Shearer W; Nicholas SK; Orange J; Chinen J; Rosenblatt H; Wu J; Bollard CM; Leung K; Brenner MK
  • Stem Cell Transplantation and Long-Term Survival for Primary Immunodeficiencies: Outcomes Among the Donor Sources and Different Diagnostic Groups
    Volume: 19 Page(s): S162 - S162
    02/01/2013 Authors: Martinez C; Shearer W; Nicholas SK; Orange J; Chinen J; Rosenblatt H; Bollard CM; Leung K; Brenner MK; Heslop HE
  • Evaluating Donor Lymphocyte Infusions (DLI) for the Treatment of Falling Chimerism, Minimal Residual Disease and Relapse After Pediatric Hematopoietic Stem Cell Transplantation (HSCT)
    Volume: 19 Page(s): S195 - S196
    02/01/2013 Authors: El-Bietar JA; Martinez C; Bollard CM; Naik S; Leung K; Gottschalk S; Ahmed N; Allen C; Heslop HE; Brenner MK
  • Administration of cord blood (CB)-derived virus-specific cytotoxic T lymphocytes to prevent CMV, adenovirus, and EBV infection after CB transplant
    Volume: 47 Page(s): S56 - S56
    04/01/2012 Authors: Hanley P; Martinez C; Melenhorst J; Leung K; Savoldo B; Leen A; Dotti G; Gee A; Rooney C; Heslop H
  • ADOPTIVE TRANSFER OF RAPIDLY-GENERATED MULTIVIRUS-SPECIFIC T CELLS TO TREAT ADENOVIRUS, EBV AND CMV INFECTIONS OF HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
    Volume: 18 Page(s): S219 - S219
    02/01/2012 Authors: Gerdemann U; Katari UL; Keirnan JM; Craddock JA; Dean TL; Liu H; Martinez CA; Kennedy-Nasser AA; Leung KS; Gottschalk S
  • IMMUNE RECONSTITUTION IN CHILDREN RECEIVING CORD BLOOD TRANSPLANTATION (CBT) WITHOUT THE USE OF LYMPHOCYTOLYTIC ANTIBODIES
    Volume: 18 Page(s): S273 - S273
    02/01/2012 Authors: Martinez CA; Chan SK; Shearer WT; Leung KS; Kennedy-Nasser AA; Bollard CM; Liu H; Wu M-F; Brenner MK; Heslop HE
  • Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease.
    J Allergy Clin Immunol Volume: 129 Page(s): 176 - 183
    01/01/2012 Authors: Martinez CA; Shah S; Shearer WT; Rosenblatt HM; Paul ME; Chinen J; Leung KS; Kennedy-Nasser A; Brenner MK; Heslop HE
  • Phase I Study to Improve Virus-Specific Immune Reconstitution After Cord Blood Transplantation Using Cord Blood-Derived Virus-Specific Cytotoxic T Lymphocytes
    Volume: 118 Page(s): 76 - 76
    11/18/2011 Authors: Hanley PJ; Martinez C; Leung K; Savaldo B; Dotti G; Gee AP; Rooney CM; Heslop HE; Krance RA; Shpall EJ
  • The clinical use of cord blood-derived virus specific cytotoxic T lymphocytes reactive against Cytomegalovirus, Adenovirus, and Epstein-Barr Virus
    Volume: 186
    04/01/2011 Authors: Hanley P; Martinez C; Leung K; Cruz CR; SavoIdo B; Rodgers J; Leen A; Dotti G; Gee A; Rooney C
  • Basic Science Award Multi-virus-specific T-cell therapy for patients after haematopoietic stem cell transplantation
    Volume: 46 Page(s): S1 - S1
    04/01/2011 Authors: Bollard CM; Leen AM; Krance RA; Leung K; Gee AP; Brenner MK; Heslop HE; Rooney CM
  • Cord blood-derived virus-specific cytotoxic T-lymphocyte therapy for cytomegalovirus, adenovirus, and Epstein-Barr virus
    Volume: 46 Page(s): S4 - S4
    04/01/2011 Authors: Bollard CM; Hanley P; Martinez C; Leung K; Cruz CRY; Krance RA; Gee AP; Liu H; Heslop HE; Rooney CM
  • STEM CELL TRANSPLANT FOR HLH: SINGLE INSTITUTION SERIES
    Volume: 17 Page(s): S263 - S264
    02/01/2011 Authors: Allen C; Martinez C; Kamdar K; Wu M-F; Leung K; Kennedy-Nasser A; Craddock J; Ahmed N; Gottschalk S; Bollard C
  • EXCELLENT SURVIVAL AFTER STEM CELL TRANSPLANTATION FOR NON-SCID PRIMARY IMMUNODEFICIENCIES
    Volume: 17 Page(s): S184 - S185
    02/01/2011 Authors: Martinez CA; Hanson IC; Rosenblatt HM; Chinen J; Leung K; Kennedy-Nasser A; Craddock J; Brenner M; Heslop H; Chokshi N
  • THE CLINICAL USE OF CORD BLOOD-DERIVED VIRUS-SPECIFIC CYTOTOXIC T LYMPHOCYTES REACTIVE AGAINST CYTOMEGALOVIRUS (CMV), ADENOVIRUS, AND EPSTEIN-BARR VIRUS (EBV)
    Volume: 17 Page(s): S158 - S158
    02/01/2011 Authors: Hanley PJ; Martinez C; Leung K; Cruz CRY; Savoldo B; Leen AM; Dotti G; Liu H; Gee AP; Rooney CM
  • Children with acute leukemia: a comparison of outcomes from allogeneic blood stem cell and bone marrow transplantation.
    Pediatr Blood Cancer Volume: 56 Page(s): 143 - 151
    01/01/2011 Authors: Lin Y-F; Lairson DR; Chan W; Du XL; Leung KS; Kennedy-Nasser AA; Martinez CA; Heslop HE; Brenner MK; Krance RA
  • The costs and cost-effectiveness of allogeneic peripheral blood stem cell transplantation versus bone marrow transplantation in pediatric patients with acute leukemia.
    Biol Blood Marrow Transplant Volume: 16 Page(s): 1272 - 1281
    09/01/2010 Authors: Lin Y-F; Lairson DR; Chan W; Du XL; Leung KS; Kennedy-Nasser AA; Martinez CA; Gottschalk SM; Bollard CM; Heslop HE
  • Immune Reconstitution Following Hematopoietic Stem Cell Transplantation in Ten Children With X-Linked (N=8) or Autosomal Recessive (N=2) Chronic Granulomatous Disease
    Volume: 135 Page(s): 288 - 288
    05/01/2010 Authors: Hanson IC; Martinez C; Shearer W; Rosenblatt H; Paul M; Leung K; Kennedy-Nasser A; Chinen J; Krance R
  • Outcome of hematopoietic stem cell transplant as salvage therapy for Hodgkin's lymphoma in adolescents and young adults at a single institution.
    Leuk Lymphoma Volume: 51 Page(s): 664 - 670
    04/01/2010 Authors: Shafer JA; Heslop HE; Brenner MK; Carrum G; Wu MF; Liu H; Ahmed N; Gottschalk S; Kamble R; Leung KS
  • A multi-center, randomized, controlled trial of parenteral nutrition titrated to resting energy expenditure in children undergoing hematopoietic stem cell transplantation ("PNTREE"): rationale and design.
    Contemp Clin Trials Volume: 31 Page(s): 157 - 164
    03/01/2010 Authors: Bechard LJ; Feldman HA; Gordon C; Gura K; Sonis A; Leung K; Venick R; Guinan EC; Duggan C
  • THE COSTS AND COST-EFFECTIVENESS OF ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION VERSUS BONE MARROW TRANSPLANTATION IN PEDIATRIC PATIENTS WITH ACUTE LEUKEMIA
    Volume: 16 Page(s): S267 - S267
    02/01/2010 Authors: Lin Y-F; Lairson DR; Chan W; Du XL; Leung KS; Kennedy-Nasser AA; Martinez CA; Bollard CM; Gottschalk SM; Heslop HE
  • CHILDREN WITH ACUTE LEUKEMIA: A COMPARISON OF OUTCOMES FROM ALLOGENEIC BLOOD STEM CELL AND BONE MARROW TRANSPLANTATION
    Volume: 16 Page(s): S290 - S291
    02/01/2010 Authors: Lin Y-F; Lairson DR; Chan W; Du XL; Leung KS; Kennedy-Nasser AA; Martinez CA; Bollard CM; Gottschalk SM; Heslop HE
  • EXCELLENT SURVIVAL AFTER MATCHED UNRELATED DONOR STEM CELL TRANSPLANTATION IN CHRONIC GRANULOMATOUS DISEASE
    Volume: 16 Page(s): S183 - S183
    02/01/2010 Authors: Martinez C; Shah S; Shearer W; Rosenblatt HM; Paul M; Chinen J; Leung K; Kennedy-Nasser AA; Hanson IC; Krance R
  • Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation.
    Blood Volume: 114 Page(s): 4283 - 4292
    11/05/2009 Authors: Leen AM; Christin A; Myers GD; Liu H; Cruz CR; Hanley PJ; Kennedy-Nasser AA; Leung KS; Gee AP; Krance RA
  • Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioning.
    J Allergy Clin Immunol Volume: 124 Page(s): 1062-9.e1-4
    11/01/2009 Authors: Patel NC; Chinen J; Rosenblatt HM; Hanson IC; Krance RA; Paul ME; Abramson SL; Noroski LM; Davis CM; Seeborg FO
  • Cytotoxic T Lymphocyte Therapy for the Treatment and Prevention of Adenovirus and Epstein Barr Virus Infections after Stem Cell Transplant
    Volume: 17 Page(s): S14 - S14
    05/01/2009 Authors: Leen AM; Christin A; Myers GD; Liu H; Gee AP; Leung K; Krance RA; Brenner MK; Heslop HE; Rooney CM
  • EXPANSION OF REGULATORY T CELLS WITH ULTRA LOW-DOSE IL-2 AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Volume: 15 Page(s): 134 - 134
    02/01/2009 Authors: Kennedy-Nasser AA; Ku S; Chaiyarat W; Foster A; Savoldo B; Yvon E; Leung KS; Carrum G; Kamble RT; Heslop HE
  • Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine.
    Biol Blood Marrow Transplant Volume: 14 Page(s): 1298 - 1304
    11/01/2008 Authors: Ahmed N; Leung KS; Rosenblatt H; Bollard CM; Gottschalk S; Myers GD; Carrum G; Heslop HE; Brenner MK; Krance RA
  • Comparable outcome of alternative donor and matched sibling donor hematopoietic stem cell transplant for children with acute lymphoblastic leukemia in first or second remission using alemtuzumab in a myeloablative conditioning regimen.
    Biol Blood Marrow Transplant Volume: 14 Page(s): 1245 - 1252
    11/01/2008 Authors: Kennedy-Nasser AA; Bollard CM; Myers GD; Leung KS; Gottschalk S; Zhang Y; Liu H; Heslop HE; Brenner MK; Krance RA
  • ALTERNATIVE DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA USING CAMPATH IN A MYELOABLATIVE CONDITIONING REGIMEN
    Volume: 14 Page(s): 83 - 83
    02/01/2008 Authors: Kennedy-Nasser AA; Myers GD; Leung KS; Gottschalk S; Bollard CM; Heslop HE; Brenner MK; Krance RA
  • SINGLE INSTITUTION'S OUTCOMES FOR FIRST TRANSPLANT AS SALVAGE THERAPY FOR HODGKIN'S LYMPHOMA
    Volume: 14 Page(s): 69 - 69
    02/01/2008 Authors: Shafer JA; Heslop HE; Carrum G; Kamble R; Myers GD; Leung KS; Bollard CM; Krance RA
  • Alternative donor transplantation for patients with acute lymphoblastic leukemia using campath in a myeloablative conditioning regimen
    Volume: 48 Page(s): 619 - 619
    06/01/2007 Authors: Kennedy-Nasser AA; Myers GD; Leung KS; Weiss H; Gottschalk S; Bollard CM; Heslop HE; Brenner MK; Krance RA
  • Stem cell transplantation (SCT) with and without conditioning for primary immune deficiency (PID) in children: A single center 25 year experience
    Volume: 13 Page(s): 128 - 128
    02/01/2007 Authors: Rosenblatt HM; Leung K; Myers GD; Shearer WT; Krance RC
  • Cytotoxic T lymphocyte therapy for the treatment and prevention of adenovirus infection after stem cell transplant
    Volume: 13 Page(s): 1 - 1
    02/01/2007 Authors: Bollard CM; Myers GD; Weiss H; Gee AP; Leung K; Krance RA; Brenner MK; Rooney CM; Heslop HE; Leen AM
  • A submyeloablative regimen of campath-1H and fludarabine for patients with graft failure following allogeneic transplantation from mhc identical or near identical donors
    Volume: 13 Page(s): 81 - 81
    02/01/2007 Authors: Ahmed N; Leung KS; Bollard CM; Gottschalk S; Myers GD; Carrum G; Heslop HE; Brenner MK; Krance RA
  • Outcome of allogeneic hematopoietic stem cell transplantation for pediatric patients with chronic myeloid leukemia
    Volume: 13 Page(s): 92 - 93
    02/01/2007 Authors: Kennedy-Nasser AA; Arce J; Leung KS; Gottschalk S; Bollard CM; Heslop HE; Brenner MK; Krance RA
  • Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia.
    Biol Blood Marrow Transplant Volume: 12 Page(s): 1277 - 1284
    12/01/2006 Authors: Kennedy-Nasser AA; Leung KS; Mahajan A; Weiss HL; Arce JA; Gottschalk S; Carrum G; Khan SP; Heslop HE; Brenner MK
  • T cell immunotherapy for adenoviral infections of stem cell transplant recipients.
    Volume: 108 Page(s): 178A - 178A
    11/16/2006 Authors: Leen AM; Myers GD; Weiss H; Gee AP; Leung KS; Krance R; Brenner MK; Rooney CM; Heslop HE; Bollard CM
  • Defective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia.
    J Cell Biol Volume: 175 Page(s): 225 - 235
    10/23/2006 Authors: Mukhopadhyay SS; Leung KS; Hicks MJ; Hastings PJ; Youssoufian H; Plon SE
  • Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals.
    Nat Med Volume: 12 Page(s): 1160 - 1166
    10/01/2006 Authors: Leen AM; Myers GD; Sili U; Huls MH; Weiss H; Leung KS; Carrum G; Krance RA; Chang C-C; Molldrem JJ
  • Outcome of alternative donor transplantation for severe aplastic anemia can be comparable to outcome with matched related donors
    Volume: 12 Page(s): 26 - 27
    02/01/2006 Authors: Kennedy-Nasser AA; Leung K; Gottschalk S; Lee DA; Carrum G; Heslop HE; Brenner MK; Bollard CM; Krance RA
  • The clinical use of donor-derived virus-specific cytotoxic T lymphocytes reactive against cytomegalovirus (CMV), adenovirus, and epstein barr virus (EBV)
    Volume: 12 Page(s): 77 - 77
    02/01/2006 Authors: Bollard CM; Myers GD; Leen A; Huls H; Buza E; Chang J; Leung K; Carrum G; Krauce RA; Molldrem J
  • T cell immunotherapy for adenoviral infections of stem cell transplant recipients.
    Volume: 8
    01/01/2006 Authors: Leen AM; Myers D; Sili U; Huls MH; Buza E; Leung K; Carrum G; Weiss H; Gee A; Krance RA
  • Outcome of alternative donor transplantation for severe aplastic anemia can be comparable to outcome with matched related donors.
    Volume: 106 Page(s): 580A - 581A
    11/16/2005 Authors: Kennedy-Nasser AA; Leung K; Gottschalk S; Lee DA; Carrum G; Heslop HE; Brenner MK; Bollard CM; Krance RA
  • Transplantation from matched unrelated donors (MUD) for Thalassemia and other congenital red cell disorders
    Volume: 106 Page(s): 770A - 771A
    11/16/2005 Authors: Leung KS; Kuehnle I; Gottschalk S; Bollard CM; Lee DA; Heslop HE; Brenner MK; Krance RA
  • The clinical use of donor-derived virus-specific cytotoxic T lymphocytes reactive against cytomegalovirus (CMV), adenovirus and Epstein Barr virus (EBV).
    Volume: 106 Page(s): 28A - 28A
    11/16/2005 Authors: Myers D; Leen AM; Sili U; Huls MH; Buza E; Leung K; Carrum G; Krance RA; Brenner MK; Rooney CM
  • Fanconi Anemia and oxidative stress: The FANCG protein interacts with Peroxiredoxin
    Volume: 73 Page(s): 354 - 354
    11/01/2003 Authors: Plon SE; Leung K; Mukhopadhyay SS; Youssoufian H
  • Cholecystitis in children with sickle cell disease undergoing cholecystectomy
    Volume: 53 Page(s): 277A - 277A
    04/01/2003 Authors: Horton TM; Suell MN; Leung KS; Pastore YD; Mahoney DH; Olutoye OO; Dishop MK; Mueller BU
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements